Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr 18;17(1):104.
doi: 10.1186/s13075-015-0623-4.

Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population

Chikashi Terao  1 , Koichiro Ohmura  2 , Yuta Kochi  3 , Katsunori Ikari  4 , Yukinori Okada  5 , Masakazu Shimizu  6 , Naoshi Nishina  7 , Akari Suzuki  8 , Keiko Myouzen  9 , Takahisa Kawaguchi  10 , Meiko Takahashi  11 , Kiyoshi Takasugi  12 , Akira Murasawa  13 , Shinichi Mizuki  14 , Mitsuhiro Iwahashi  15 , Keiko Funahashi  16 , Masamitsu Natsumeda  17 , Moritoshi Furu  18 , Motomu Hashimoto  19 , Hiromu Ito  20 , Takao Fujii  21 , Kazuhiko Ezawa  22 , Tsukasa Matsubara  23 , Tsutomu Takeuchi  24 , Michiaki Kubo  25 , Ryo Yamada  26 , Atsuo Taniguchi  27 , Hisashi Yamanaka  28 , Shigeki Momohara  29 , Kazuhiko Yamamoto  30 , Tsuneyo Mimori  31 , Fumihiko Matsuda  32   33
Affiliations
Review

Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population

Chikashi Terao et al. Arthritis Res Ther. .

Abstract

Introduction: Although susceptibility genes for anti-citrullinated peptide/protein antibodies (ACPA)-positive rheumatoid arthritis (RA) have been successfully discovered by genome-wide association studies (GWAS), little is known about the genetic background of ACPA-negative RA. We intended to elucidate genetic background of ACPA-negative RA.

Method: We performed a meta-analysis of GWAS comprising 670 ACPA-negative RA and 16,891 controls for 1,948,138 markers, followed by a replication study of the top 35 single nucleotide polymorphisms (SNPs) using 916 cases and 3,764 controls. Inverse-variance method was applied to assess overall effects. To assess overlap of susceptibility loci between ACPA-positive and -negative RA, odds ratios (ORs) of the 21 susceptibility markers to RA in Japanese were compared between the two subsets. In addition, SNPs were stratified by the p-values in GWAS meta-analysis for either ACPA-positive RA or ACPA-negative RA to address the question whether weakly-associated genes were also shared. The correlations between ACPA-positive RA and the subpopulations of ACPA-negative RA (rheumatoid factor (RF)-positive and RF-negative subsets) were also addressed.

Results: Rs6904716 in LEMD2 of the human leukocyte antigen (HLA) locus showed a borderline association with ACPA-negative RA (overall p = 5.7 × 10(-8)), followed by rs6986423 in CSMD1 (p = 2.4 × 10(-6)) and rs17727339 in FCRL3 (p = 1.4 × 10(-5)). ACPA-negative RA showed significant correlations of ORs with ACPA-positive RA for the 21 susceptibility SNPs and non-HLA SNPs with p-values far from significance. These significant correlations with ACPA-positive RA were true for ACPA-negative RF-positive and ACPA-negative RF-negative RA. On the contrary, positive correlations were not observed between the ACPA-negative two subpopulations.

Conclusion: Many of the susceptibility loci were shared between ACPA-positive and -negative RA.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Manhattan plot of meta-analysis of three genome-wide association studies (GWAS) for anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis. The horizontal line indicates the GWAS significance level (P = 5 × 10−8).
Figure 2
Figure 2
Correlation of odds ratios (ORs) of rheumatoid arthritis (RA) susceptibility single nucleotide polymorphisms (SNPs) for anti-citrullinated peptide/protein antibody (ACPA)-positive RA and those for ACPA-negative RA. (A) Correlations of ORs regarding the 21 susceptibility SNPs to RA for ACPA-positive and -negative RA. The upper panel shows the results in the genome-wide association studies (GWAS) meta-analysis and the lower panel shows the results in the replication study. (B) ORs of the 21 SNPs in RA-susceptibility loci for ACPA-negative RA in the combined analysis (blue line) and ACPA-positive RA (red line) are plotted. Mean +/− 95% CI are shown. (C) Correlation coefficient of ORs between ACPA-positive and -negative RA in terms of SNPs stratified by P-values for ACPA-positive RA. *P-values <1.0 × 10−7. SNPs in the HLA locus were excluded from this analysis.
Figure 3
Figure 3
Correlations of odds ratios (ORs) in sets of non-human leukocyte antigen (HLA) single nucleotide polymorphisms (SNPs) among anti-citrullinated peptide/protein antibody (ACPA)-positive rheumatoid arthritis (RA) and the two subsets of ACPA-negative RA. Correlation coefficient of ORs between ACPA-positive RA and ACPA-negative RF-positive RA (A), between ACPA-positive RA and ACPA-negative RF-negative RA (B), and between ACPA-negative RF-positive RA and ACPA-negative RF-negative RA (C), in terms of SNPs stratified by p-values of ACPA-positive RA (A, B) or each study (C). *Positive correlation with P-values <1.0 × 10−7. SNPs in the HLA locus were excluded from this analysis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000;43:30–37. doi: 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B. - DOI - PubMed
    1. Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van’t Hof M, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000;43:1831–1835. doi: 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6. - DOI - PubMed
    1. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998;101:273–281. doi: 10.1172/JCI1316. - DOI - PMC - PubMed
    1. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43:155–163. doi: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3. - DOI - PubMed
    1. Ohmura K, Terao C, Maruya E, Katayama M, Matoba K, Shimada K, et al. Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis. Rheumatology (Oxford). 2010;49:2298–2304. doi: 10.1093/rheumatology/keq273. - DOI - PMC - PubMed

Substances